Loading clinical trials...
Loading clinical trials...
Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells to Augment Single or Double Myeloablative Cord Blood Transplantation in Patients With Hematologic Malignancies
Conditions
Interventions
umbilical cord blood transplantation
fludarabine phosphate
+6 more
Locations
1
United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
August 1, 2010
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
March 5, 2019
NCT03147612
NCT02159495
NCT02220985
NCT01822015
NCT00093470
NCT01904136
Lead Sponsor
Nohla Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions